MyJournals Home  

RSS FeedsEndocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity (Future Oncology)

 
 

21 january 2020 18:00:28

 
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity (Future Oncology)
 




Future Oncology, Ahead of Print.


Del.icio.us Digg Facebook Google StumbleUpon Twitter
 
58 viewsCategory: Oncology
 
A different video-assisted thoracoscopic approach for every patient or for every surgeon? (Future Oncology)
Eribulin-based treatment in patients affected by sarcomas: a case series (Future Oncology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology

Use these buttons to bookmark us:
Del.icio.us Digg Facebook Google StumbleUpon Twitter


Valid HTML 4.01 Transitional
Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn